Worth Asset Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
DAS
FBT
AA
FFA
CA
SRCM
Worth Asset Management's BTAL Position: Q2 2026 in Review
Worth Asset Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 30,472 shares — an estimated $425K sold.
Worth Asset Management first reported a position in BTAL in Q1 2022 and held it in 13 quarters. The position peaked at $3.33M in Q4 2022. 6 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Worth Asset Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
- Worth Asset Management sold 30,472 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $425K.
- Worth Asset Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2022 and held it in 13 quarters.
- Worth Asset Management's AGF US Market Neutral Anti-Beta Fund position peaked at $3.33M in Q4 2022.
- 6 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Worth Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.